Literature DB >> 34090392

Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany.

Christian Staerk1, Tobias Wistuba2, Andreas Mayr2.   

Abstract

BACKGROUND: The infection fatality rate (IFR) of the Coronavirus Disease 2019 (COVID-19) is one of the most discussed figures in the context of this pandemic. In contrast to the case fatality rate (CFR), the IFR depends on the total number of infected individuals - not just on the number of confirmed cases. In order to estimate the IFR, several seroprevalence studies have been or are currently conducted.
METHODS: Using German COVID-19 surveillance data and age-group specific IFR estimates from multiple international studies, this work investigates time-dependent variations in effective IFR over the course of the pandemic. Three different methods for estimating (effective) IFRs are presented: (a) population-averaged IFRs based on the assumption that the infection risk is independent of age and time, (b) effective IFRs based on the assumption that the age distribution of confirmed cases approximately reflects the age distribution of infected individuals, and (c) effective IFRs accounting for age- and time-dependent dark figures of infections.
RESULTS: Effective IFRs in Germany are estimated to vary over time, as the age distributions of confirmed cases and estimated infections are changing during the course of the pandemic. In particular during the first and second waves of infections in spring and autumn/winter 2020, there has been a pronounced shift in the age distribution of confirmed cases towards older age groups, resulting in larger effective IFR estimates. The temporary increase in effective IFR during the first wave is estimated to be smaller but still remains when adjusting for age- and time-dependent dark figures. A comparison of effective IFRs with observed CFRs indicates that a substantial fraction of the time-dependent variability in observed mortality can be explained by changes in the age distribution of infections. Furthermore, a vanishing gap between effective IFRs and observed CFRs is apparent after the first infection wave, while an increasing gap can be observed during the second wave.
CONCLUSIONS: The development of estimated effective IFR and observed CFR reflects the changing age distribution of infections over the course of the COVID-19 pandemic in Germany. Further research is warranted to obtain timely age-stratified IFR estimates, particularly in light of new variants of the virus.

Entities:  

Keywords:  COVID-19; Dark figures; Infection fatality rate; Mortality; SARS-CoV-2

Year:  2021        PMID: 34090392     DOI: 10.1186/s12889-021-11127-7

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  7 in total

1.  Bayesian inference across multiple models suggests a strong increase in lethality of COVID-19 in late 2020 in the UK.

Authors:  Patrick Pietzonka; Erik Brorson; William Bankes; Michael E Cates; Robert L Jack; Ronojoy Adhikari
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

2.  The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable?

Authors:  Beny Spira
Journal:  Cureus       Date:  2022-07-01

3.  Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic.

Authors:  Aurélie Godbout; Mélanie Drolet; Myrto Mondor; Marc Simard; Chantal Sauvageau; Gaston De Serres; Marc Brisson
Journal:  BMC Med       Date:  2022-05-23       Impact factor: 11.150

4.  A statistical model for the dynamics of COVID-19 infections and their case detection ratio in 2020.

Authors:  Marc Schneble; Giacomo De Nicola; Göran Kauermann; Ursula Berger
Journal:  Biom J       Date:  2021-08-10       Impact factor: 1.715

5.  Estimating the course of the COVID-19 pandemic in Germany via spline-based hierarchical modelling of death counts.

Authors:  Tobias Wistuba; Andreas Mayr; Christian Staerk
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

6.  Dynamical regulations on mobility and vaccinations for controlling COVID-19 spread.

Authors:  Mevan Rajakaruna; Harshana Rajakaruna; Rupika Rajakaruna
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

7.  Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant.

Authors:  Fabian Ullrich; Christine Hanoun; Amin T Turki; Tobias Liebregts; Katharina Breuckmann; Ferras Alashkar; Hans Christian Reinhardt; Bastian von Tresckow; Julia von Tresckow
Journal:  Eur J Haematol       Date:  2022-07-16       Impact factor: 3.674

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.